IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,185 | -9.3% | 57,594 | -10.4% | 0.00% | – |
Q2 2023 | $327,747 | -1.6% | 64,264 | -0.7% | 0.00% | – |
Q1 2023 | $333,148 | +87340.4% | 64,689 | +4.1% | 0.00% | – |
Q4 2022 | $381 | -99.8% | 62,170 | +175.3% | 0.00% | – |
Q3 2022 | $169,000 | -7.7% | 22,579 | +7.4% | 0.00% | – |
Q2 2022 | $183,000 | -2.1% | 21,016 | +8.4% | 0.00% | – |
Q1 2022 | $187,000 | +20.6% | 19,393 | 0.0% | 0.00% | – |
Q4 2021 | $155,000 | -18.4% | 19,393 | -5.5% | 0.00% | – |
Q3 2021 | $190,000 | +3.3% | 20,514 | +5.7% | 0.00% | – |
Q2 2021 | $184,000 | +26.0% | 19,408 | +28.6% | 0.00% | – |
Q1 2021 | $146,000 | – | 15,096 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
Creative Planning | 310 | $1,000 | 0.00% |
Renaissance Technologies | 10,000 | $38,000 | 0.00% |
UBS AG | 1,870 | $7,000 | 0.00% |
US BANCORP \DE\ | 24 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
MORGAN STANLEY | 29,628 | $111,000 | 0.00% |